• Citer

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience

par Bielen, Rob;De Galocsy, Chantal;Janssens, F.;Van Overbeke, Lode;van Steenkiste, Christophe;D'Heygere, François;Cool, Mike M.R.;Wuyckens, K.;Nevens, Frederik;Robaeys, Geert;Moreno, Christophe ;Van Vlierberghe, Hans;Bourgeois, Stefan;Mulkay, Jean-Pierre ;Vanwolleghem, Thomas;Verlinden, Wim;Brixco, C.;Decaestecker, Jochen
Référence Journal of viral hepatitis, 24, 11, page (976-981)
Publication Publié, 2017-11

Article révisé par les pairs

• Détails
• Contenu

Titre:	The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience
Auteur:	Bielen, Rob; De Galocsy, Chantal; Janssens, F.; Van Overbeke, Lode; van Steenkiste, Christophe; D'Heygere, François; Cool, Mike M.R.; Wuyckens, K.; Nevens, Frederik; Robaeys, Geert; Moreno, Christophe; Van Vlierberghe, Hans; Bourgeois, Stefan; Mulkay, Jean-Pierre; Vanwolleghem, Thomas; Verlinden, Wim; Brixco, C.; Decaestecker, Jochen
Informations sur la publication:	Journal of viral hepatitis, 24, 11, page (976-981)
Statut de publication:	Publié, 2017-11
Sujet CREF:	Virologie médicale
	Virologie générale
	Pathologie maladies infectieuses
	Gastro-entérologie
Mots-clés:	direct-acting antiviral therapy
	hepatitis C
	hepatocellular carcinoma
	pegylated interferon
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1352-0504
	info:doi/10.1111/jvh.12726
	info:scp/85031408431